| scholarly article | Q13442814 |
| P50 | author | Chenglai Xia | Q97419290 |
| P2093 | author name string | Chang Liu | |
| Yantao Cai | |||
| Zhihong He | |||
| Jinman Chen | |||
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| p53 in the DNA-Damage-Repair Process | Q28073944 | ||
| Functions of natural killer cells | Q29614300 | ||
| Targeting PI3K signalling in cancer: opportunities, challenges and limitations | Q29617685 | ||
| Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis | Q33597162 | ||
| Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K/Akt signaling pathway | Q33825014 | ||
| Retracted: 3, 3'-Diindolylmethane Exhibits Antileukemic Activity In Vitro and In Vivo through a Akt-Dependent Process | Q34171365 | ||
| Expression of MICA, MICB and NKG2D in human leukemic myelomonocytic and cervical cancer cells | Q34855104 | ||
| MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer | Q34995302 | ||
| AMPK-HDAC5 pathway facilitates nuclear accumulation of HIF-1α and functional activation of HIF-1 by deacetylating Hsp70 in the cytosol | Q36186609 | ||
| Metformin impairs the growth of liver kinase B1-intact cervical cancer cells. | Q36205053 | ||
| LY294002, a PI3K pathway inhibitor, prevents leptin-induced adverse effects on spermatozoa in Sprague-Dawley rats | Q93232976 | ||
| Combining metformin and nelfinavir exhibits synergistic effects against the growth of human cervical cancer cells and xenograft in nude mice | Q37676300 | ||
| Is there a biological plausability for p53 codon 72 polymorphism influence on cervical cancer development? | Q37889425 | ||
| MICA polymorphism: biology and importance in cancer | Q38261462 | ||
| Metformin: A Novel but Controversial Drug in Cancer Prevention and Treatment | Q38597773 | ||
| An Ancient, Unified Mechanism for Metformin Growth Inhibition in C. elegans and Cancer | Q38725828 | ||
| Dual Role of p21 in the Progression of Cancer and Its Treatment. | Q38856127 | ||
| A hypoxia-induced decrease of either MICA/B or Hsp70 on the membrane of tumor cells mediates immune escape from NK cells | Q38967996 | ||
| The endogenous danger signals HSP70 and MICA cooperate in the activation of cytotoxic effector functions of NK cells. | Q39689690 | ||
| Valproic acid inhibits the growth of cervical cancer both in vitro and in vivo | Q39976555 | ||
| Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells | Q40108262 | ||
| Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells | Q40216291 | ||
| Association between Metformin Use and Mortality after Cervical Cancer in Older Women with Diabetes. | Q41006137 | ||
| Constitutive release of IL6 by human papillomavirus type 16 (HPV16)-harboring keratinocytes: a mechanism augmenting the NK-cell-mediated lysis of HPV-bearing neoplastic cells | Q41673592 | ||
| The HPV E6/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets. | Q41947880 | ||
| Altered phenotype and function of NK cells infiltrating human papillomavirus (HPV)-associated genital warts during HIV infection | Q42232352 | ||
| Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials | Q44634881 | ||
| Evaluation of short- and long-term efficacy of chemoradiotherapy for advanced cervical cancer using HSP70 protein combined with multimodal MRI. | Q47662747 | ||
| Achieving ADA/ISPAD clinical guideline goals is associated with higher insulin sensitivity and cardiopulmonary fitness in adolescents with type 1 diabetes: Results from RESistance to InSulin in Type 1 ANd Type 2 diabetes (RESISTANT) and Effects of M | Q47725249 | ||
| The Potential Value of the PI3K/Akt/mTOR Signaling Pathway for Assessing Prognosis in Cervical Cancer and as a Target for Therapy | Q48185689 | ||
| Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells. | Q50001260 | ||
| HSP70 inhibitor combined with cisplatin suppresses the cervical cancer proliferation in vitro and transplanted tumor growth: An experimental study. | Q51122640 | ||
| Targeting the PI3K pathway in cancer: are we making headway? | Q52672314 | ||
| Metformin: Restraining Nucleocytoplasmic Shuttling to Fight Cancer and Aging. | Q52812521 | ||
| MHC class I chain-related gene A (MICA) polymorphism and the different histological types of cervical cancer. | Q53657903 | ||
| Metformin and Autoimmunity: A "New Deal" of an Old Drug. | Q55240881 | ||
| Vorinostat, a pan-HDAC inhibitor, abrogates productive HPV-18 DNA amplification | Q58576079 | ||
| Hsp90 and Hsp70 chaperones: Collaborators in protein remodeling | Q58607367 | ||
| Roles of heat shock factor 1 beyond the heat shock response | Q60017544 | ||
| High Glucose with Insulin Induces Cell Cycle Progression and Activation of Oncogenic Signaling of Bladder Epithelial Cells Cotreated with Metformin and Pioglitazone | Q61799673 | ||
| High glucose promotes pancreatic cancer cells to escape from immune surveillance via AMPK-Bmi1-GATA2-MICA/B pathway | Q64056215 | ||
| Targeting Chemoresistant Tumors: Could TRIM Proteins-p53 Axis Be a Possible Answer? | Q64059648 | ||
| NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment | Q64102223 | ||
| Targeting PI3K in cancer: mechanisms and advances in clinical trials | Q64254413 | ||
| Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer | Q79349338 | ||
| Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) | Q82672660 | ||
| Metformin, a first-line drug for type 2 diabetes mellitus, disrupts the MALAT1/miR-142-3p sponge to decrease invasion and migration in cervical cancer cells | Q88500195 | ||
| The Effect of Metformin on Oncological Outcomes in Patients With Cervical Cancer With Type 2 Diabetes Mellitus | Q88813151 | ||
| Recent Advances in Molecular Mechanisms of the NKG2D Pathway in Hepatocellular Carcinoma | Q89782122 | ||
| The Hsp70-Hsp90 Chaperone Cascade in Protein Folding | Q90019327 | ||
| Cancer statistics, 2019 | Q90941571 | ||
| NKT-like cells reveal higher than T lymphocytes expression of cellular protective proteins HSP70 and SOD2 and comparably increased expression of SIRT1 in the oldest seniors | Q91000072 | ||
| Metformin combined with nelfinavir induces SIRT3/mROS-dependent autophagy in human cervical cancer cells and xenograft in nude mice | Q91268385 | ||
| HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia | Q91682182 | ||
| PI3K/AKT/mTOR Signaling Regulates the Virus/Host Cell Crosstalk in HPV-Positive Cervical Cancer Cells | Q91783484 | ||
| iTRAQ-based quantitative proteomic analysis of the inhibition of cervical cancer cell invasion and migration by metformin | Q92171540 | ||
| The relation between PI3K/AKT signalling pathway and cancer | Q92230403 | ||
| Receptor tyrosine kinases in PI3K signaling: The therapeutic targets in cancer | Q92822761 | ||
| Metformin Modulates Cyclin D1 and P53 Expression to Inhibit Cell Proliferation and to Induce Apoptosis in Cervical Cancer Cell Lines | Q93059348 | ||
| P433 | issue | 1 | |
| P921 | main subject | metformin | Q19484 |
| P304 | page(s) | 127 | |
| P577 | publication date | 2020-07-06 | |
| P1433 | published in | Journal of Experimental & Clinical Cancer Research | Q13739415 |
| P1476 | title | Metformin inhibits cervical cancer cell proliferation by modulating PI3K/Akt-induced major histocompatibility complex class I-related chain A gene expression | |
| P478 | volume | 39 |
Search more.